1+ day, 15+ hour ago  (351+ words) Reg Med Net is part of Taylor & Francis Group. Original story from the University of Maryland School of Medicine (UMSOM; MD, USA). Researchers have demonstrated how blocking a specific protein keeps CAR-T cells fighting cancer longer, potentially improving outcomes for…...

1+ day, 16+ hour ago  (598+ words) Reg Med Net Reg Med Net is part of Taylor & Francis Group. Taylor & Francis Group is a trading division of Informa that operates through various Informa legal entities including, but not limited to, Informa UK Limited, with the registered address…...

3+ day, 16+ hour ago  (721+ words) Reg Med Net is part of Taylor & Francis Group. Since we now know that cell therapy isn't just hypothetical " that these cells can really become therapies " the real need is driving the success of them through the rigor of process…...

3+ day, 15+ hour ago  (173+ words) Reg Med Net is part of Taylor & Francis Group. The Novo Nordisk Foundation, an independent enterprise foundation, has released a comprehensive report outlining a strategic pathway to position Europe as a global leader in regenerative medicine." In 2025, the Novo Nordisk…...

1+ week, 22+ hour ago  (236+ words) Reg Med Net is part of Taylor & Francis Group. This week: The first patient has been dosed with the first non-viral gene-edited T-cell therapy to be evaluated in Europe, Syntax Bio (IL, USA) and Mayo Clinic (MN, USA) have announced…...

1+ week, 1+ day ago  (520+ words) Reg Med Net is part of Taylor & Francis Group. Original story from The University of Texas MD Anderson Cancer Center (TX, USA). A novel platform utilizing extracellular vesicles (EVs) to deliver messenger RNA (m RNA) encoding the DMD gene safely…...

1+ week, 1+ day ago  (62+ words) Reg Med Net Reg Med Net is part of Taylor & Francis Group. Taylor & Francis Group is a trading division of Informa that operates through various Informa legal entities including, but not limited to, Informa UK Limited, with the registered address…...

3+ week, 18+ hour ago  (591+ words) Reg Med Net is part of Taylor & Francis Group. Original story from The University of Edinburgh (Scotland). A new type of cell therapy shows promise as the first treatment for advanced liver disease, following results from a clinical trial. Patients…...

3+ week, 20+ hour ago  (221+ words) Reg Med Net is part of Taylor & Francis Group. Eli Lilly and Company announced positive Phase Ib Heart-2 study results for VERVE-102, an investigational in vivo base editing therapy designed to permanently turn off the PCSK9 gene and lower low-density lipoprotein…...

3+ week, 4+ day ago  (215+ words) Reg Med Net is part of Taylor & Francis Group. Recent advances in regenerative medicine, including cell and gene therapies, are paving the way for innovative approaches to repair damage caused by MS and potentially alter the course of the disease....